study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir
The recently published study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir.
News reports are saying Proscar is "virtually worthless"... prompting lots of calls from concerned patients.
This is the same study we alerted you to last year...it's just now been published in the New England Journal of Medicine.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote